FiercePharmaAsia—Eisai's Lenvima nods, Alzheimer's cut; Sanofi exits Bangladesh; Henlius IPO
admin 20th September 2019 Uncategorised 0Keytruda-Lenvima combo wins three simultaneous OKs. Eisai’s Biogen-partnered BACE program in Alzheimer’s disease reached its end. Sanofi is reportedly leaving Bangladesh. Fosun-backed Henlius Biotech raises $410 million in Hong Kong IPO. And more. More: FiercePharmaAsia—Eisai's Lenvima nods, Alzheimer's cut; Sanofi
read more